By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Rosetta Genomics Ltd. 

10 Plaut Street

Rehovot    76706  Israel
Phone: 972-0-8-9484755 Fax: 972-0-8-9484766



Company News
Rosetta Genomics (ROSG) Release: Aegis Restates "Buy" Rating On Shares Of Rosetta Genomics 1/12/2017 9:11:58 AM
Rosetta Genomics (ROSG) Enters Research Collaboration Using Microrna Biomarkers To Predict Response To Leading Immuno-Oncology Drug Nivolumab In Lung Cancer Patients 11/21/2016 11:08:41 AM
Rosetta Genomics (ROSG) Release: Clinical Validation Study For RosettaGX Reveal Published In The Journal Of Clinical Pathology 10/27/2016 11:00:53 AM
Toft Group Completes Chief Commercial Officer Search For Rosetta Genomics (ROSG) In Princeton, NJ 10/27/2016 10:04:55 AM
Rosetta Genomics (ROSG) Release: RosettaGX Reveal Analytical Validation Study Featured On The Cover Of The October Issue Of Cancer Cytopathology 10/24/2016 11:10:56 AM
Rosetta Genomics (ROSG) Appoints Mark R. Willig As Chief Commercial Officer 10/20/2016 11:08:36 AM
Rosetta Genomics (ROSG) Fortifies Intellectual Property Portfolio With Two New Patent Allowances For Its Novel MicroRNA Platform Technology 10/3/2016 9:00:46 AM
Rosetta Genomics (ROSG) Enters Distribution Agreement For Rosettagx Reveal In Israel With Rhenium 9/29/2016 10:46:13 AM
Rosetta Genomics (ROSG) To Host 2016 Second Quarter Financial Results And Business Update Conference Call On September 26, 2016 9/20/2016 11:52:41 AM
Rosetta Genomics (ROSG) Release: Data Validating The Utility Of Rosettagx Reveal With Liquid-Based Cytology Samples Will Be Presented At The 86th Annual Meeting Of The American Thyroid Association 9/14/2016 12:12:08 PM